Ipragliflozin or Sitagliptin in T2D With Metformin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A 52-Week Randomized Controlled Trial of Ipragliflozin or Sitagliptin in Type 2 Diabetes Combined With Metformin: The N-ISM Study
Diabetes Obes Metab 2021 Jan 08;[EPub Ahead of Print], M Kitazawa, T Katagiri, H Suzuki, S Matsunaga, M H Yamada, T Ikarashi, M Yamamoto, K Furukawa, M Iwanaga, M Hatta, K Fujihara, T Yamada, S Tanaka, H SoneFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.